Clasificación en acciones
#14023
Operating as a clinical-stage biotechnology firm, Q32 Bio Inc. is dedicated to... Operating as a clinical-stage biotechnology firm, Q32 Bio Inc. is dedicated to developing biologic therapies aimed at re-establishing healthy immune equilibrium in patients across the United States suffering from autoimmune and inflammatory disorders stemming from dysfunctional immune responses. The company's primary investigational therapy, ADX-097, is a humanized anti-C3d monoclonal antibody fusion protein designed to normalize complement regulation. This candidate has successfully finished its Phase I clinical trial, targeting severe renal and other complement-driven conditions where patient needs are largely unmet, such as lupus nephritis, IgA nephropathy, C3 glomerulopathy, and ANCA-associated vasculitis. Additionally, Q32 Bio is advancing Bempikibart (ADX-914), a fully human monoclonal antibody antagonist against interleukin-7 receptor alpha. Currently in Phase II trials, Bempikibart aims to recalibrate adaptive immune responses by inhibiting signaling pathways involving interleukin-7 and thymic stromal lymphopoietin, offering potential treatment for atopic dermatitis and alopecia areata. Founded in 2017 and headquartered in Waltham, Massachusetts, Q32 Bio Inc. adopted its current name in April 2020, having previously operated as AdMIRx Inc.
Capitalización bursátil
$442.29M
Comercio Q32 Bio Inc. (QTTB)
Precio QTTB con Capital del mercado a B
Capitalización de mercado de Q32 Bio Inc.(QTTB)
Capitalización bursátil: $442.29M
A fecha de August 2026, Q32 Bio Inc. tiene una capitalización de mercado de $442.29M. Esto convierte a Q32 Bio Inc. en la 14023rd empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Q32 Bio Inc. desde 2018 hasta 2026
QTTB en comparación con los más populares 5 títulos stocks
| Precio por QTTB |
|
Activo B |
Capital del mercado en B |
Resultados |
|
|
|
|
$5.327T
|
+1,204,260.77%
|
|
|
|
|
$4.645T
|
+1,050,080.81%
|
|
|
|
|
$4.070T
|
+920,163.32%
|
|
|
|
|
$3.785T
|
+855,572.62%
|
|
|
|
|
$2.790T
|
+630,731.31%
|
